Vicarious Surgical names Joseph Doherty board chair

Q: Who is Joseph Doherty in relation to Vicarious Surgical (RBOT)?

Joseph Doherty is a director of Vicarious Surgical who was elected at the June 27, 2025 annual meeting and now serves as Chairman of the Board.

Q: What committees does Joseph Doherty serve on at Vicarious Surgical?

Joseph Doherty is a member of the board’s Compensation Committee and serves as Chairman of the Nominating and Corporate Governance Committee.

Q: Did Vicarious Surgical issue a press release about the new Chairman?

Yes. Vicarious Surgical issued a press release dated September 25, 2025 announcing Joseph Doherty’s appointment as Chairman, furnished as Exhibit 99.1.

Q: Is the press release about Vicarious Surgical’s Chairman considered filed with the SEC?

No. The press release furnished as Exhibit 99.1 is not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference, except if specifically stated in another filing.

Vicarious Surgical Inc. reported a leadership change on its board of directors.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Vicarious Surgical Inc. reported a leadership change on its board of directors. On September 25, 2025, the board appointed Joseph Doherty to serve as Chairman of the Board. He joined the board earlier in the year following his election at the annual meeting of stockholders held on June 27, 2025.

Doherty already serves as a member of the board’s Compensation Committee and as Chairman of the Nominating and Corporate Governance Committee, indicating an active role in executive pay decisions and board oversight. The company also issued a press release announcing his appointment, which is furnished as an exhibit but is not considered filed for liability purposes under securities laws.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Vicarious Surgical (RBOT) disclose in this 8-K?

The company disclosed that its board of directors appointed Joseph Doherty as Chairman of the Board effective September 25, 2025.

Who is Joseph Doherty in relation to Vicarious Surgical (RBOT)?

Joseph Doherty is a director of Vicarious Surgical who was elected at the June 27, 2025 annual meeting and now serves as Chairman of the Board.

What committees does Joseph Doherty serve on at Vicarious Surgical?

Joseph Doherty is a member of the board’s Compensation Committee and serves as Chairman of the Nominating and Corporate Governance Committee.

Did Vicarious Surgical issue a press release about the new Chairman?

Yes. Vicarious Surgical issued a press release dated September 25, 2025 announcing Joseph Doherty’s appointment as Chairman, furnished as Exhibit 99.1.

Is the press release about Vicarious Surgical’s Chairman considered filed with the SEC?

No. The press release furnished as Exhibit 99.1 is not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference, except if specifically stated in another filing.

Who signed this Vicarious Surgical (RBOT) 8-K filing?

The report was signed on behalf of Vicarious Surgical Inc. by Stephen From, the company’s Chief Executive Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 09/25/2025 - 04:15 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 25, 2025

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39384		87-2678169
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

78 Fourth Avenue
Waltham, Massachusetts		02451
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 868-1700

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A common stock, par value $0.0001 per share	RBOT	The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share	RBOT WS	The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 25, 2025, Vicarious Surgical Inc. (the “Company”) announced that its board of directors (the “Board”) has appointed Joseph Doherty to serve as Chairman of the Board. Mr. Doherty joined the Board following his election at the Company’s annual meeting of stockholders held on June 27, 2025, and he currently serves as a member of the Board’s Compensation Committee and as the Chairman of the Board’s Nominating and Corporate Governance Committee.

On September 25, 2025, the Company issued a press release announcing the appointment of Mr. Doherty as Chairman of the Board. A copy of the press release is furnished as Exhibit 99.1 hereto.

Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.		Description
99.1		Press Release dated September 25, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICARIOUS SURGICAL INC.

	By:	/s/ Stephen From
	Name:	Stephen From
	Title:	Chief Executive Officer

Date: September 25, 2025

Source: View Original Filing on SEC EDGAR

Vicarious Surgical names Joseph Doherty board chair

Rhea-AI Filing Summary

Positive

Negative